CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 24 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | -100.0% | 21 | -99.4% | 0.00% | – |
| Q1 2018 | $7,000 | -36.4% | 3,576 | -49.0% | 0.00% | – |
| Q4 2017 | $11,000 | 0.0% | 7,010 | +34.8% | 0.00% | – |
| Q3 2017 | $11,000 | +57.1% | 5,201 | +6.4% | 0.00% | – |
| Q2 2017 | $7,000 | -61.1% | 4,887 | -57.5% | 0.00% | – |
| Q1 2017 | $18,000 | -74.3% | 11,500 | -39.5% | 0.00% | – |
| Q4 2016 | $70,000 | +483.3% | 18,998 | +849.9% | 0.00% | – |
| Q3 2016 | $12,000 | +20.0% | 2,000 | -22.0% | 0.00% | – |
| Q2 2016 | $10,000 | +233.3% | 2,565 | +413.0% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 500 | +431.9% | 0.00% | – |
| Q4 2015 | $1,000 | -85.7% | 94 | -88.3% | 0.00% | – |
| Q3 2015 | $7,000 | – | 805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $4,572,000 | 5.05% |
| Clarus Ventures, LLC | 2,752,488 | $4,404,000 | 3.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 388,030 | $621,000 | 0.12% |
| Rhenman & Partners Asset Management AB | 310,756 | $497,000 | 0.08% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $39,000 | 0.01% |
| OPPENHEIMER & CO INC | 90,000 | $144,000 | 0.00% |
| Alyeska Investment Group, L.P. | 221,281 | $354,000 | 0.00% |
| A.R.T. Advisors, LLC | 46,747 | $74,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,347 | $162,000 | 0.00% |
| Acrospire Investment Management LLC | 680 | $1,000 | 0.00% |